Ceva Lung Program Allows Pig Industry to 'Breathe Easy'19 March 2013
THAILAND - Respiratory disease is the most frequent and economically significant disease affecting swine production worldwide. Certain respiratory infections, like Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae are present on over 90 per cent of farms worldwide and are therefore also a major threat to animal welfare.
Ceva is committed to improving pig respiratory health through the development of vaccines such as Coglapix, Auphyl Plus and the innovative, new Hyogen that prevent the development of such diseases.
Vaccines, like any tools, are much more effective when using "the right tool for the right job." In this way, Ceva is now proud to introduce the Ceva Lung Program, combined with its respiratory vaccine range. The Ceva Lung Program will make easier to evaluate the presence and impact of the main respiratory pathogens on farm and then to monitor the results of any health interventions implemented. Simple guidelines and a handy iPad app. are the backbone of the new respiratory health program that swine farms will find easy-to-use.
Commenting on the introduction of the new program, Dr Stefano Gozio, Head of Ceva’s Swine business said: "Our goal is to work together with veterinarians and producers to assist them in achieving better preventative respiratory health on their farms. We need to create partnerships that lead to answers and in that way, we will all be able to "breathe easy"."
The Ceva Lung program is another example of how Ceva is partnering to meet its mission: Together, beyond animal health.
|ThePigSite News Desk|